Elevance Health sets July 15 call on Q2 2026 results
Elevance Health (NYSE: ELV) will release its second-quarter 2026 financial results on July 15, 2026, at 6:00 a.m. EDT. Management will discuss these results and provide their outlook during a conference call and live webcast scheduled for 8:30 a.m. EDT on the same day. A webcast replay will be available until August 14, 2026.
UnitedHealth Bets on Profitability Over Growth: Will It Pay Off?
UnitedHealth Group (UNH) is shifting its focus from rapid enrollment growth to improving profitability due to a challenging operating environment. The company is repricing Medicare Advantage plans, exiting less profitable markets, and leveraging Optum's growth in value-based care and technology services. This strategic reset, showing early signs of success with improved first-quarter earnings and MCR, aims to restore earnings momentum and ensure long-term sustainability, an approach also being adopted by peers like Cigna and Elevance Health.
UnitedHealth Bets on Profitability Over Growth: Will It Pay Off?
UnitedHealth (UNH) is shifting its strategy from rapid enrollment growth to focus on profitability due to higher healthcare utilization and rising Medicare Advantage costs. The company is repricing plans, exiting less profitable markets, and leveraging Optum as a growth driver through value-based care and technology. Peers like Cigna (CI) and Elevance Health (ELV) are also prioritizing efficiency and quality growth in a challenging healthcare environment.
CMS proposes expanded authority to revoke Medicare privileges
CMS is proposing to expand its authority to revoke Medicare provider privileges as part of an effort to crack down on healthcare fraud, waste, and abuse. The proposed rule would allow CMS to remove providers for additional reasons, including operating in areas with an "excessive" number of providers, convictions related to sexual assault or financial misconduct, or issues with owners' licenses in other states. These changes, part of the Calendar Year 2027 Home Health Prospective Payment System Proposed Rule, aim to save taxpayers an estimated $82 million annually while also updating home health payments with a 2.4% increase.
UnitedHealth Group underscores its role in U.S. health coverage as investors watch long term growth
UnitedHealth Group is a major player in the U.S. healthcare sector, integrating insurance and health services. The company's diversified model and involvement in public programs like Medicare and Medicaid are key factors for investors evaluating its long-term growth prospects. Its ability to balance growth with cost management in a highly regulated industry is also a significant consideration.
Can Centene's Fraud Prevention Strategy Support Margin Recovery?
Centene Corporation is enhancing its fraud prevention efforts through advanced analytics and AI-enabled tools to improve profitability in its government-sponsored healthcare businesses. This strategy, particularly effective in Medicaid, helped increase Q1 2026 adjusted EPS by 16.2% and improved the Medicaid health benefits ratio. These initiatives aim to strengthen cost controls and provide a competitive advantage, with competitors like UnitedHealth Group and Elevance Health also focusing on similar strategies.
Can Centene's Fraud Prevention Strategy Support Margin Recovery?
Centene Corporation is enhancing its fraud, waste, and abuse prevention strategies, using advanced analytics and AI, to improve profitability in its government-sponsored healthcare businesses. These efforts have already contributed to improved Medicaid margins in Q1 2026, leading to raised EPS guidance for the year. Competitors like UnitedHealth Group and Elevance Health are also focusing on similar AI-driven payment integrity measures.
Elevance Health focuses on managed care growth and digital health strategy
Elevance Health is focusing on expanding its managed care and services portfolio by emphasizing digital tools, value-based care, and diversification across different health plans. The company aims to manage healthcare costs and improve member outcomes through these initiatives. It also invests in digital health tools and integrated health plans to strengthen member relationships and streamline care coordination.
Insurer Elevance Seeks Recalculated Medicare Star Rating in Lawsuit
Elevance Health has filed a lawsuit against the CMS, seeking a recalculation of its 2026 Medicare Star Rating. The insurer claims the CMS inconsistently applied rules by recalculating a competitor's (Clover Health) ratings after a court ruling, while denying the same treatment to Elevance, which it estimates will cost the company $115 million in 2027 quality bonus payments. Elevance argues that the same 20 measures deemed unlawful for Clover also impacted its own ratings and that all similarly situated parties should receive equal treatment under administrative law.
UnitedHealth Group highlights diversified health benefits and services portfolio as investors track long-term growth drivers
UnitedHealth Group Incorporated continues to emphasize its diversified portfolio of health benefits and services. The company's dual structure as both an insurer and a services provider, combining commercial, Medicare, and Medicaid plans with pharmacy benefits and data analytics, is a key feature. Investors are closely monitoring membership trends, medical cost management, and the company's role in the broader U.S. healthcare system.
Anthem Blue Cross and USA TODAY Launch Video Series to Help Americans Navigate Health Care
Anthem Blue Cross and USA TODAY Network's GET Creative have partnered to launch a new five-part video series aimed at helping Americans better understand their health plan benefits, make informed care decisions, and manage costs. Hosted by Emmy and Critics' Choice Award-winning actress Katherine LaNasa, the series covers essential health insurance terms, choosing appropriate care settings, and strategies to avoid unexpected medical expenses. LaNasa, a breast cancer survivor and Anthem member, shares her personal experience to emphasize the importance of understanding healthcare options.
Anthem Blue Cross and Blue Shield and USA TODAY Launch Video Series to Help Americans Navigate Health Care
Anthem Blue Cross and Blue Shield and USA TODAY Network's GET Creative have launched a new five-part video series aimed at helping Americans understand their health plan benefits, make informed care decisions, and manage costs. Hosted by Emmy and Critics' Choice Award-winning actress Katherine LaNasa, the series covers essential health insurance terms, how to choose the right place for care, and strategies to avoid unexpected medical expenses. LaNasa, an Anthem member and breast cancer survivor, shared her personal experience to emphasize the importance of understanding healthcare options.
Elevance Health focuses on managed care strategy as a major US insurer
Elevance Health remains a key player in the US managed care sector, adapting its strategy to evolving regulations and market expectations. The company focuses on expanding in high-growth segments, improving medical cost management through technology, and diversifying into health services beyond traditional insurance. Elevance Health's integrated health benefits solutions aim to simplify member experience and coordinate care.
Molina Healthcare outlines its managed care strategy as a US Medicaid specialist
Molina Healthcare specializes in government-sponsored health plans, primarily focusing on Medicaid, Medicare, and Affordable Care Act (ACA) marketplaces. The company operates as a managed care organization, contracting with state agencies to provide health benefits to vulnerable populations, emphasizing care coordination and cost control. Its business model, which includes a diversified portfolio of government-related health plans, is attractive to investors interested in publicly funded healthcare.
Elevance Health Stock Slips Pre-Market After Slashing Full-Year Earnings Guidance: Retail Now Eyes UnitedHealth Q2 Results
Elevance Health (NYSE:ELV) shares fell before market open after the company lowered its full-year EPS guidance due to an expected increase in medical costs for the second quarter. The revised forecast puts its adjusted net income per share between $37.75 and $38.00, down from the previous range of at least $38.50. This announcement follows a similar warning from UnitedHealth (NYSE:UNH), which also noted higher medical costs, leading to broader sector concerns.
Molina Healthcare highlights Medicaid and Medicare strength as managed care demand grows
Molina Healthcare is focusing on its Medicaid and Medicare managed care business, which benefits from strong demand for government-sponsored health coverage in the U.S. The company's strategy emphasizes stable enrollment, disciplined cost management, and diversification through Medicare Advantage and health insurance marketplace plans. Success hinges on winning and retaining state and federal contracts, managing medical costs, and demonstrating quality outcomes.
Can Elevance Recover $115 Million Through Its CMS Lawsuit?
Elevance Health, Inc. (ELV) has filed a lawsuit against the Centers for Medicare & Medicaid Services (CMS) after CMS allegedly unfairly altered a competitor's Medicare Advantage Star Ratings post-finalization. Elevance claims this cost them approximately $115 million in quality bonus payments and created an uneven competitive landscape. The company seeks to overturn CMS's decision and restore a consistent ratings process for all Medicare Advantage insurers.
HUM - Humana Inc Latest SEC Filings
This article provides the latest SEC filing information and comprehensive financial data for Humana Inc. (HUM). It details various financial metrics such as market cap, income, sales, P/E ratios, dividend information, and performance indicators, alongside insider ownership and institutional transactions. The data reflects the company's financial health and stock performance as of July 2, 2024.
CVS Health Corp. highlights evolving role in U.S. healthcare. Investors weigh integrated care strategy
CVS Health Corp. is expanding its integrated healthcare model, combining pharmacy, insurance, and clinical services to achieve long-term stability in the evolving U.S. healthcare landscape. The company's diversified approach, spanning retail pharmacies, pharmacy benefit management, and health insurance, aims to create a comprehensive care ecosystem. Investors are evaluating how effectively this integrated structure can translate into resilient earnings and improved patient outcomes through coordinated care.
Can Centene's Integrated Healthcare Model Support Earnings Growth?
Centene's integrated healthcare model, combining government health plans with clinical, pharmacy, and community-based services, is expected to support its earnings growth. The company serves 26.3 million members, allowing for economies of scale, and is leveraging technology and data analytics to manage costs and improve outcomes. Despite regulatory challenges, Centene's investments in technology and clinical programs are set to drive margin recovery and sustainable long-term earnings growth.
Elevance Health sues over Medicare Advantage star ratings
Elevance Health has filed a lawsuit against the Centers for Medicare and Medicaid Services (CMS) regarding the recalculation of the 2026 Medicare Advantage star ratings. The CMS plans to redo these star ratings for all insurance providers. The article highlights other related news in politics and regulation, including HHS freezing New York's Medicaid fraud unit funds and CMS proposing changes to hospital outpatient pay and 340B cuts.
Elevance sues government over $115 million tied to Medicare Advantage star ratings
Elevance Health has filed a lawsuit against the U.S. government, claiming that the recalculation of its Medicare Advantage quality ratings did not comply with a recent court decision, resulting in a $115 million loss for the insurer. The lawsuit, filed in Georgia, focuses on the star ratings system which dictates taxpayer-funded bonuses and rebates for health plans based on quality and customer service.
Cigna Brings AI to Specialty Pharmacy With Pharmacy Forward
Cigna's health services division, Evernorth, has launched Pharmacy Forward, an AI-powered specialty pharmacy initiative backed by a $100 million investment. This program aims to simplify prescription journeys, reduce processing times by half, and improve patient adherence for complex conditions. With projections to generate nearly $400 million in cumulative value by 2028, this initiative strengthens Evernorth's position in the growing specialty pharmacy market and contributes to Cigna's long-term growth strategy.
Can Centene's Integrated Healthcare Model Support Earnings Growth?
Centene Corporation's integrated healthcare model, combining government-sponsored health plans with coordinated clinical services, is supporting its earnings potential by effectively managing medical costs and improving health outcomes. The company is leveraging technology and data, including AI, to enhance operational capabilities and pricing decisions. Despite regulatory challenges, these efforts, along with its strong first-quarter 2026 performance and raised EPS guidance, position Centene for sustainable long-term growth, competing with giants like UnitedHealth and Elevance Health.
Elevance Health sues over Medicare Advantage star ratings
Elevance Health has filed a lawsuit against the Centers for Medicare and Medicaid Services (CMS) regarding the recalculation of 2026 Medicare Advantage star ratings. The CMS plans to redo the star ratings for all insurers, which prompted Elevance Health's legal action. This article reports on the lawsuit and details the specific date and time of its publication.
Elevance Health stock hits 52-week high at 427.07 USD
Elevance Health stock reached a new 52-week high of $427.07, indicating strong investor confidence with a 22.61% increase over the past year. Analysts from Bernstein SocGen Group, Mizuho, and Deutsche Bank have raised price targets and upgraded ratings due to solid quarterly results and a positive outlook. The company also announced that shareholders elected directors and approved executive pay at its recent annual meeting, maintaining a conservative guidance on Medicaid enrollment for 2026.
Elevance Health stock hits 52-week high at 427.07 USD
Elevance Health (ELV) stock recently reached a 52-week high of $427.07, indicating strong investor confidence and positive market sentiment. The company reported robust first-quarter fiscal 2026 results, with adjusted earnings surpassing estimates, leading several firms like Bernstein SocGen Group and Deutsche Bank to raise price targets and upgrade ratings. These developments highlight Elevance Health's strong position and strategic execution in the healthcare sector.
Elevance Health stock hits 52-week high at 427.07 USD By Investing.com
Elevance Health Inc. (ELV) stock reached a new 52-week high of $427.07, trading at $426.33 with a market capitalization of $91.93 billion. The healthcare giant has shown a 22.61% increase over the past year, reflecting strong investor confidence and positive market sentiment. Analyst ratings from Bernstein SocGen Group, Mizuho, and Deutsche Bank have raised price targets and upgraded the stock, following strong first-quarter fiscal 2026 results.
Molina Healthcare focuses on managed care growth as investors watch US health coverage trends
Molina Healthcare, a US-based managed care company, specializes in providing health insurance services through government programs like Medicaid and Medicare. The company's growth and profitability are closely tied to enrollment levels, effective management of medical costs relative to fixed payments, and the ever-changing policy environment surrounding public health coverage. Investors closely monitor these factors, along with regulatory developments and industry performance, to assess Molina Healthcare's financial health and future prospects.
Top National Health Plan Extends Agreement for Mental Health and Expands Dario Partnership into Cardiometabolic Care, Demonstrating Successful Multi-Condition Growth Strategy
DarioHealth Corp. announced that a top national health insurer has expanded its partnership to include Dario's hypertension solution, following the success of its behavioral health offering. This expansion is expected to approximately triple Dario's revenue opportunity with this customer and validates its multi-condition strategy. It marks the third health plan customer to broaden its deployment beyond an initial condition, reinforcing Dario's ability to grow within its existing customer base by delivering integrated care across various chronic conditions.
Elevance Health (ELV) Enhances Health OS to Automate Clinical Reviews and Reduce Provider Administrative Burdens
Elevance Health (ELV) has significantly enhanced its Health OS platform to automate clinical reviews and reduce administrative burdens for healthcare providers. This advancement has led to a 61% drop in prior authorization denials and faster decision-making, with over 42% of electronic prior authorization requests processed in under one minute. By streamlining processes and improving communication between payers and providers, Elevance Health aims to create a more efficient and predictable care journey for patients.
Elevance Health Inc. stock outperforms competitors on strong trading day
Shares of Elevance Health Inc. (ELV) rose 7.62% to $416.19 on Wednesday, outperforming the broader market which saw the S&P 500 Index and Dow Jones Industrial Average decline. This gain broke a two-day losing streak for the stock.
ELV - Elevance Health Inc Volatility & Greeks
This article provides a detailed financial overview of Elevance Health Inc (ELV), including its recent stock performance, key financial metrics, and options-related data. It lists various ratios, historical performance, and insider/institutional ownership percentages. The data indicates strong growth in sales and dividends but a slight decrease in EPS for the trailing twelve months.
ELV - Elevance Health Inc Latest SEC Filings
This article provides the latest SEC filings and comprehensive financial data for Elevance Health Inc (ELV). It includes key metrics such as market capitalization, income, sales, dividend information, various financial ratios, earnings per share (EPS) estimates, insider and institutional ownership, profitability ratios, and stock performance data. The company's last close was $386.73, with a slight decrease of 0.34% on June 30th.
Plus Therapeutics to rebrand as Cerenome and adopt CNSY ticker on August 3 (PSTV)
Plus Therapeutics, a healthcare company focusing on CNS cancers, announced it will rebrand as Cerenome and trade under the new Nasdaq ticker CNSY starting August 3, 2026. The company also reaffirmed its 2026 guidance, highlighting increased insurance coverage for its CNSide diagnostics platform and progress in its clinical programs for REYOBIQ. CEO Marc H. Hedrick stated the new name reflects its identity as an "integrated CNS oncology platform company."
Plus Therapeutics to rebrand as Cerenome, change ticker to CNSY
Plus Therapeutics (NASDAQ:PSTV) will rebrand as Cerenome and change its ticker symbol to CNSY, starting August 3, 2026. The company, which specializes in central nervous system cancers, currently trades at $4.29 with a market capitalization of $29.7 million, despite a 66.5% year-to-date decline. This change comes as the company expands commercial payer coverage for its CNSide CSF Tumor Cell Enumeration assay and progresses its therapeutic programs.
Centene Corp. consensus picture on Wall Street, shares trade on the NYSE
Centene Corp. opens Tuesday with a steady analyst consensus on Wall Street, focusing on earnings expectations, valuation, and positioning among U.S. health insurance peers. The company, a U.S. managed-care and Medicaid specialist, is covered by major research houses like Goldman Sachs and JPMorgan. Analysts monitor metrics such as revenue growth, operating margins, and price-to-earnings multiples against competitors like UnitedHealth Group.
How payers, drugmakers can collaborate to drive more outcomes-based contracts
The article discusses the growing need for collaboration between payers and drug manufacturers to manage rising drug costs and promote value-based care. Cigna Group's Brian Evanko and EMD Serono's Miguel Fernández Alcalde highlighted their successful partnership in reducing fertility treatment costs as an example. They advocate for expanded outcomes-based pricing models, especially for high-cost therapies, stressing the importance of involving all stakeholders to balance innovation with affordability.
SCHD ETF: Why this 'anti-AI' fund is beating the S&P 500 and Nasdaq 100 indices
The Schwab US Dividend Equity ETF (SCHD) has demonstrated strong performance and significant inflows this year, outperforming major indices like the S&P 500 and Nasdaq 100, despite limited exposure to the AI sector. The fund's success is attributed to its concentration in traditional industries like healthcare and consumer staples, with top holdings like UnitedHealth Group and Merck experiencing substantial growth. This positioning makes SCHD a potential hedge against an AI market slowdown, and technical analysis suggests continued upward momentum.
Elevance Health Inc. stock outperforms competitors despite losses on the day
Shares of Elevance Health Inc. (ELV) fell 1.81% on Monday, closing at $388.03, breaking a two-day winning streak despite a generally positive trading session for the broader stock market. The S&P 500 Index increased by 1.18% and the Dow Jones Industrial Average rose by 0.59%. Despite its daily loss, the company's stock still outperformed some competitors, though the article highlights a loss rather than outperformance.
Elevance Health Foundation Awards $5.8 Million to Expand Behavioral Health Programs Nationwide
The Elevance Health Foundation has granted $5.8 million to nearly 40 organizations across the U.S. to enhance access to behavioral health services, addressing barriers like provider shortages and stigma. This investment is part of a larger $150 million commitment aimed at improving mental health care and substance use disorder treatment in underserved communities. The funded programs will focus on community-based care, strengthening local support systems, and improving outcomes for individuals facing social and economic risks.
ACA Marketplace premiums might see a double-digit spike in 2027
A preliminary analysis indicates that ACA Marketplace premiums could see double-digit rate hikes in 2027 in some states. This is primarily attributed to the lapse of enhanced premium tax credits, uncertainty surrounding the Notice of Benefit and Payment Parameters (NBPP), and rising healthcare costs. These factors are expected to lead to smaller, sicker risk pools and increased financial burdens for many middle-income earners and uninsured individuals.
Elevance Health (ELV) Fell Amid Healthcare Sector Downturn
Elevance Health (ELV) saw its stock fall during the first quarter of 2026, detracting from the performance of Heartland Advisors' Opportunistic Value Equity Strategy, despite the strategy outperforming its benchmark. The healthcare sector faced challenges like elevated utilization and medical cost inflation, impacting ELV's margins. However, Heartland Advisors views Elevance Health as a strong long-term prospect due to its robust balance sheet and market position, trading at a discount compared to the Russell 3000® Value Index.
Elevance Health (ELV) Fell Amid Healthcare Sector Downturn
Heartland Advisors' "Heartland Opportunistic Value Equity Strategy" reported that Elevance Health (NYSE
Elevance Health (ELV) Fell Amid Healthcare Sector Downturn
Elevance Health, Inc. (ELV) experienced a decline in performance during the first quarter of 2026, detracting from the Heartland Opportunistic Value Equity Strategy. The healthcare sector faced challenges including elevated utilization, medical cost inflation, and policy disruptions, impacting all industry players. Despite these headwinds, Heartland Advisors believes Elevance Health is well-positioned to gain market share due to its strong balance sheet and scale, trading at a discount compared to the Russell 3000® Value Index.
American Well Corporation(NYSE: AMWL) added to Russell Microcap Index
American Well Corporation (NYSE: AMWL) has been added to the Russell Microcap Index. The company operates a hybrid care delivery enablement platform, connecting providers, payers, patients, and innovators to facilitate access to quality care. This addition highlights the growing recognition of Amwell's role in the digital health sector.
Elevance Health, Inc.(NYSE: ELV) dropped from Russell 1000 Defensive Index
Elevance Health, Inc. (NYSE: ELV) has been removed from the Russell 1000 Defensive Index. This news was published on June 29, 2026, at 12:30 am EDT. The article also includes recent news updates for Elevance Health, such as coverage agreements and adjusted EPS guidance for 2026.
Elevance Health, Inc.(NYSE: ELV) added to Russell 1000 Dynamic Index
Elevance Health, Inc. (NYSE: ELV) has been added to the Russell 1000 Dynamic Index on June 28, 2026. This news comes amidst other recent activity for the company, including adjustments to price targets by Bernstein and JPMorgan, and its removal from the Russell 1000 Value-Defensive and Defensive Indices. Elevance Health, a leading American health insurance provider, also recently announced advancements in its Health OS and new services.
Centene cautious on workforce plans, shares hold steady in S&P 500 healthcare group
Centene Corporation is under scrutiny for planned workforce reductions while RBC Capital initiates coverage with a "Sector Perform" rating and a $70 price target. Despite potential execution risks in Medicaid and Marketplace operations, the managed-care stock remains a key player in the S&P 500 healthcare sector, with shares showing positive year-to-date performance. The company's strategy involves streamlining operations for cost savings and margin expansion.
Centene (CNC) Appoints Lauren M. Tyler To Board With JPMorgan Leadership Experience
Centene (CNC) has appointed Lauren M. Tyler to its Board of Directors, bringing extensive leadership experience from JPMorgan Chase & Co. in finance, audit, and human capital strategy. This appointment is expected to influence board-level priorities such as capital allocation, risk oversight, and executive oversight, particularly as Centene focuses on cost structure reviews and membership shifts. Investors are advised to monitor future disclosures and governance updates to understand the impact of her role on the company's long-term decision-making and operational efficiency.
